These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 18495946

  • 21. Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.
    Miyawaki S, Kobayashi T, Tanimoto M, Kuriyama K, Murakami H, Yoshida M, Minami S, Minato K, Tsubaki K, Omoto E, Oh H, Jinnai I, Sakamaki H, Hiraoka A, Kanamaru A, Takahashi I, Saito K, Naoe T, Yamada O, Asou N, Kageyama S, Emi N, Ueda T, Tomonaga M, Ohno R.
    Int J Hematol; 1999 Jul; 70(1):56-7. PubMed ID: 10446497
    [No Abstract] [Full Text] [Related]

  • 22. A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.
    Lancet JE, Baer MR, Duran GE, List AF, Fielding R, Marcelletti JF, Multani PS, Sikic BI.
    Leuk Res; 2009 Aug; 33(8):1055-61. PubMed ID: 19108889
    [Abstract] [Full Text] [Related]

  • 23. Two cases of post-liver transplant acute myeloid leukemia in Korean adults: review of bibliographies and comparison with post-renal transplant acute myeloid leukemia.
    Cho YU, Chi HS, Park CJ, Seo EJ, Lee JH, Lee JH, Lee SG.
    Ann Hematol; 2008 Jun; 87(6):513-4. PubMed ID: 18299830
    [No Abstract] [Full Text] [Related]

  • 24. Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia.
    Decker RW, Ho WG, Champlin RE.
    Cancer Treat Rep; 1987 Sep; 71(9):881-2. PubMed ID: 3476204
    [No Abstract] [Full Text] [Related]

  • 25. Disseminated tuberculosis treated with amikacin in a patient with acute myelocytic leukemia.
    Engervall P, Kalin M, Björkholm M.
    Acta Oncol; 1997 Sep; 36(4):444-6. PubMed ID: 9247111
    [No Abstract] [Full Text] [Related]

  • 26. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
    Li GY, Liu JZ, Zhang B, Wang LX, Wang CB, Chen SG.
    Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
    [Abstract] [Full Text] [Related]

  • 27. [Diagnosis and intensive treatment of acute leukemia in pregnancy].
    Sierra J, Urbano Ispizua A, Cararach V, Carreras E, Fortuny A, Grañena A, Rozman C.
    Med Clin (Barc); 1987 Jan 10; 88(1):28-31. PubMed ID: 3469488
    [No Abstract] [Full Text] [Related]

  • 28. Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemia.
    Talbot DC, Montes A, Teh WL, Nandi A, Powles RL.
    Hosp Med; 1998 Jul 10; 59(7):580-1. PubMed ID: 9798551
    [No Abstract] [Full Text] [Related]

  • 29. [Acute myelogenous leukemia associated with severe esophageal stricture after chemotherapy].
    Yata K, Yamada O, Iwato K, Kyo T, Otsuki T, Nakanishi H, Suetsugu Y, Mikami M, Wada H, Yawata Y, Sugihara T.
    Rinsho Ketsueki; 2002 Jan 10; 43(1):41-3. PubMed ID: 11868364
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia.
    Jakl M, Horacek JM, Jebavy L, Pudil R.
    Leuk Res; 2009 Aug 10; 33(8):e109-10. PubMed ID: 19237194
    [No Abstract] [Full Text] [Related]

  • 33. [Analysis on clinical response of IA and DA regimens in the treatment of 74 newly diagnosed acute myeloid leukemia patients].
    Li XY, Wang X, Li Y.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jan 10; 34(1):67-8. PubMed ID: 23597470
    [No Abstract] [Full Text] [Related]

  • 34. [The role of zorubicine in the treatment of acute myeloid leukemia. Evaluation of 15 years' use].
    Marty M, Gisselbrecht C, Schaison G, Bauters F, Guy H, Bordessoule D, Lepage E, Gemont-Auclerc MF, Boiron M.
    Pathol Biol (Paris); 1987 Feb 10; 35(2):133-7. PubMed ID: 3550620
    [No Abstract] [Full Text] [Related]

  • 35. Aclacinomycin-A in the induction treatment of childhood acute myelogenous leukemia.
    Fink FM, Grümayer ER, Kardos G, Revesz T, Gadner H, Schuler D.
    Haematol Blood Transfus; 1987 Feb 10; 30():393-8. PubMed ID: 3305209
    [No Abstract] [Full Text] [Related]

  • 36. [IAG regimen for patients with refractory/relapsed acute myeloid leukemia].
    Yang Y, Ji CF, Zhang YM, Liu LM, He GS, Jin ZM, Ma X, Xue SL, He XF, Wu DP, Sun AN.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jul 10; 34(7):637-8. PubMed ID: 23906465
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Relapse and death during first remission in acute myeloid leukemia.
    Yanada M, Garcia-Manero G, Borthakur G, Ravandi F, Kantarjian H, Estey E.
    Haematologica; 2008 Apr 10; 93(4):633-4. PubMed ID: 18379012
    [No Abstract] [Full Text] [Related]

  • 39. Isolated Bilateral Ear and Scalp Rash After Cytarabine Therapy for Acute Myelogenous Leukemia: A Report and Literature Review.
    Waseem H, Henriquez Felipe C, Hashmi AT, Ansar M, Batool A, Saverimuthu A, Kamholz SL.
    Am J Ther; 2019 Apr 10; 26(5):e653-e655. PubMed ID: 30418222
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.